DEVICE CATEGORY · NOX
Filler, Bone Void, Synthetic Peptide
The device acts as a bone void filler and consists of a filling material and a synthetic peptide. It is intended to fill traumatic or surgically-created defects that are not intrinsic to the bony structure of the extremities, spine or pelvis. It will be packed or placed into the defect and will resorb over time to be replaced by bone.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
i-F ACTOR Peptide Enhanced Graft SubstituteP140019/S014 | Cerapedics, LLC | PMA supplement | Sep 16, 2026 | FDA |
PearlMatrixTM Peptide Enhanced Bone GraftP240001/S003 | Cerapedics, Inc. | PMA supplement | Sep 16, 2026 | FDA |
PearlMatrix Bone GraftP240001 | Cerapedics, Inc. | PMA approval | Jun 18, 2025 | FDA |
| Cerapedics, LLC | PMA approval | Nov 3, 2015 | FDA |
Source information
Follow the FDA links to view the original records.

